CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common stock	Capital in excess of par value	Treasury shares at cost	Accumulated other comprehensive income (loss)	Accumulated deficit	Total stock- holders’ equity	Non- controlling interests
Shares, Issued, Beginning Balance at Dec. 31, 2019		281,437
Beginning balance at Dec. 31, 2019	$ 9,655	$ 64	$ 15,184	$ (3,037)	$ 75	$ (2,845)	$ 9,441	$ 214
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(13)					(21)	(21)	8
Other comprehensive income	(61)				(61)		(61)
Share-based compensation plans	108		108				108
Shares issued pursuant to stock awards (in shares)		497
Shares issued pursuant to stock awards	29			47		(18)	29
Treasury share repurchase and retired (in shares)		(2,933)
Treasury shares repurchased and retired	(355)			(355)			(355)
Expiration of stock purchase warrants	0		(56)			56	0
Dividends common stock	(105)					(105)	(105)
Balance (in shares) at Mar. 29, 2020		279,001
Ending balance at Mar. 29, 2020	9,258	$ 64	15,236	(3,345)	14	(2,933)	9,036	222
Shares, Issued, Beginning Balance at Dec. 31, 2020		280,475
Beginning balance at Dec. 31, 2020	9,151	$ 59	14,133	(1,037)	117	(4,328)	8,944	207
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	364					353	353	11
Other comprehensive income	(56)				(56)		(56)
Share-based compensation plans	91		91				91
Shares issued pursuant to stock awards (in shares)		361
Shares issued pursuant to stock awards	31			37		(6)	31
Treasury share repurchase and retired (in shares)		(5,087)
Treasury shares repurchased and retired	(905)			(905)			(905)
Dividends common stock	(155)					(155)	(155)
Balance (in shares) at Apr. 04, 2021		275,749
Ending balance at Apr. 04, 2021	$ 8,521	$ 59	$ 14,224	$ (1,905)	$ 61	$ (4,136)	$ 8,303	$ 218